tellmeGen
PrivateLast Round
Accelerator
Jun 1, 2014
Total Funding Raised
$272,000
Company Overview
tellmeGen is a biotechnology company that provides direct-to-consumer genetic testing services, including health, ancestry, and pharmacogenetic reports.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
tellmeGen Comparables
Compare tellmeGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 24Genetics | 93% | |
| Living DNA | 89% | |
| CRI Genetics | 85% |
tellmeGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2014 |
Key People
Founding team and executive leadership
tellmeGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lanzadera | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Grew 19% QoQ, from 31 to 37 employees.
- Jun 1, 2014
$272K raised from Lanzadera.
tellmeGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about tellmeGen's valuation, stock price, and market status.
Is tellmeGen a public or private company?
tellmeGen is a private company.
What is the current stock price of tellmeGen?
tellmeGen is a private company with no public stock price. No recent secondary market data is available.
How much is tellmeGen worth (valuation)?
Valuation information for tellmeGen is not publicly available.
Can I buy tellmeGen stock?
tellmeGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was tellmeGen's last funding round?
tellmeGen's most recent funding round was Accelerator on June 1, 2014.
Who are the main investors in tellmeGen?
Key investors in tellmeGen include Lanzadera.
Will tellmeGen IPO soon?
No public IPO plans have been announced for tellmeGen.
How can I track tellmeGen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor tellmeGen's secondary market activity and sign up for updates.